LifeDX Africa provides accurate and affordable point-of-care diagnostic solutions designed to support early detection, disease control, and local manufacturing capacity in Africa
About Us
Company Overview
Founded
2023
Core business
Medical Device Research & Development and Manufacturing
Headquarters
Lausanne, Switzerland
Our Expertise
Advanced Medical Device Development
Specializing in High-Tech Solutions
Global Regulatory Expertise
Our team is experienced with leading authorities worldwide, including US FDA, CE Marking, and emerging markets.
Committed to Excellence
We are ISO 13485:2016 certified and adhere to the stringent requirements of WHO, Global Fund, and PATH.
Uncompromising Control
Maintained throughout every stage of R&D and manufacturing.
Powered by Cutting-Edge Technology
Utilizing the latest advancements across every stage of development and manufacturing.
Mission
Our mission is improving access to accurate, affordable, and timely diagnostic solutions that support early diagnosis, effective treatment decisions, and stronger public health systems.
Vision
Our goal is building resilient diagnostic ecosystems in Africa and other high-burden regions by enabling local manufacturing, technology transfer, and sustainable access to essential diagnostic products.
Our Mission & VISION
Lateral Flow (LF)
Lateral flow tests are rapid immunochromatographic assays designed to detect specific antigens, antibodies, or biomarkers in clinical or other sample types. They provide visual results on a nitrocellulose strip, typically enclosed in a plastic cassette.
Enzyme-linked immunosorbent assays (ELISA) are plate-based immunoassays used to detect and quantify analytes such as proteins, antibodies, antigens, and hormones in biological samples.